Literature DB >> 7469017

Determination of serum and plasma uridine levels in mice, rats, and humans by high-pressure liquid chromatography.

J M Karle, L W Anderson, D D Dietrick, R L Cysyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7469017     DOI： 10.1016/0003-2697(80)90007-x

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  12 in total

1.  Metabolic engineering generates a transgene-free safety switch for cell therapy.

Authors:  Volker Wiebking; James O Patterson; Renata Martin; Monica K Chanda; Ciaran M Lee; Waracharee Srifa; Gang Bao; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2020-07-13       Impact factor: 54.908

2.  The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors.

Authors:  Christine R Cuthbertson; Hui Guo; Armita Kyani; Joseph T Madak; Zahra Arabzada; Nouri Neamati
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-23

Review 3.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

4.  Pseudouridine and uridine in normal kidney and kidney cancer tissues.

Authors:  K Koshida; J Harmenberg; E Borgström; B Wahren; L Andersson
Journal:  Urol Res       Date:  1985

Review 5.  The concentrative nucleoside transporter family, SLC28.

Authors:  Jennifer H Gray; Ryan P Owen; Kathleen M Giacomini
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

6.  Comparison of the bioavailability of uridine in mice after either oral or parenteral administration.

Authors:  P Klubes; D B Geffen; R L Cysyk
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole.

Authors:  M Markman; T C Chan; S Cleary; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Determination of ribonucleosides, deoxyribonucleosides, and purine and pyrimidine bases in adult rabbit cerebrospinal fluid and plasma.

Authors:  J T Eells; R Spector
Journal:  Neurochem Res       Date:  1983-10       Impact factor: 3.996

9.  Uridine pharmacokinetics in cancer patients.

Authors:  T C Chan; M Markman; C E Pfeifle; R Taetle; I Abramson; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2.

Authors:  Wendy P Painter; Wayne Holman; Jim A Bush; Firas Almazedi; Hamzah Malik; Nicola C J E Eraut; Merribeth J Morin; Laura J Szewczyk; George R Painter
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.